比较基线[68Ga]Ga-FAPI-04 PET/CT与[18F]F-FDG PET/CT在胰腺导管腺癌中的临床价值:远端胰腺炎的额外预后价值
本研究纳入49例经组织学确诊的局限性胰腺导管腺癌(PDAC)患者,其中32例同期接受60分钟动态[68Ga]Ga-FAPI-04 PET/CT。静态[68Ga]Ga-FAPI-04在原发灶、转移淋巴结及远处转移的准确性和摄取值均显著高于[18F]F-FDG;与增强CT分期相比,[68Ga]Ga-FAPI-04和[18F]F-FDG分别使18.4%和10.2%的患者分期改变。联合全胰腺[68Ga]Ga-FAPI-04与[18F]F-FDG摄取可进一步按术后预后对患者分层。
要点
- 静态[68Ga]Ga-FAPI-04对PDAC原发灶、淋巴结和远处转移的准确性与摄取值均显著高于[18F]F-FDG。
- [68Ga]Ga-FAPI-04使18.4%、[18F]F-FDG使10.2%的患者分期较增强CT发生改变。
- 全胰腺联合[68Ga]Ga-FAPI-04与[18F]F-FDG摄取可进一步按术后预后分层。
核心结论
- 对于增强CT识别的PDAC,[68Ga]Ga-FAPI-04 PET/CT在肿瘤、淋巴结和转移分期上比[18F]F-FDG PET/CT更敏感和准确。
- [68Ga]Ga-FAPI-04摄取与病理侵袭性肿瘤特征显著相关。
- 联合[68Ga]Ga-FAPI-04与[18F]F-FDG PET/CT表现提高了预后价值,可能为临床管理提供无创指导。
- PDAC所致梗阻性胰腺炎中成纤维细胞活性增加可能与患者生存率差相关。
研究设计与样本
- 研究纳入增强CT疑为局限性PDAC的患者,接受静态[68Ga]Ga-FAPI-04与[18F]F-FDG PET/CT,部分患者同期接受60分钟动态[68Ga]Ga-FAPI-04 PET/CT。
- 共纳入49例经组织学确诊的PDAC腺癌患者,其中32例接受60分钟动态[68Ga]Ga-FAPI-04 PET/CT显像。
- 通过勾画原发肿瘤、全胰腺和远端胰腺感兴趣区评估静态PET/CT的诊断与分期性能,并分析PET/CT表现与临床病理特征的相关性。
- 采用Kaplan-Meier和风险比(log-rank)方法评估联合动态[68Ga]Ga-FAPI-04与静态[18F]F-FDG PET/CT方法的预后价值。
主要发现
- 静态[68Ga]Ga-FAPI-04方法在原发PDAC病灶、转移淋巴结和远处转移方面,准确性和摄取值均显著高于静态[18F]F-FDG方法。
- 与增强CT指定的分期相比,使用[68Ga]Ga-FAPI-04和[18F]F-FDG PET/CT方法后分别有18.4%和10.2%的患者分期发生改变。
- 动态[68Ga]Ga-FAPI-04 PET/CT获得的Ki值在PDAC与远端梗阻性胰腺炎病灶之间无差异。
- 病理学肿瘤体积增大、分化差和神经周围侵犯与[68Ga]Ga-FAPI-04摄取增加相关,但与[18F]F-FDG摄取无关。
- 术前[68Ga]Ga-FAPI-04的预后性能优于[18F]F-FDG;全胰腺联合[68Ga]Ga-FAPI-04与[18F]F-FDG摄取结果可进一步按术后预后对患者分层。
关键数值与推荐
- 静态[68Ga]Ga-FAPI-04在原发PDAC病灶、转移淋巴结和远处转移的准确性和摄取值均显著高于静态[18F]F-FDG。
- [68Ga]Ga-FAPI-04使18.4%的患者分期改变,[18F]F-FDG使10.2%的患者分期改变(均与增强CT分期比较)。
- 动态[68Ga]Ga-FAPI-04的Ki值在PDAC与远端梗阻性胰腺炎病灶间无差异。
- 病理学肿瘤体积增大、分化差和神经周围侵犯与[68Ga]Ga-FAPI-04摄取增加相关,与[18F]F-FDG摄取无关。
临床怎么用
- 原文结论认为[68Ga]Ga-FAPI-04 PET/CT在增强CT识别的PDAC的肿瘤、淋巴结和转移分期上比[18F]F-FDG PET/CT更敏感和准确。
- 原文结论认为联合[68Ga]Ga-FAPI-04与[18F]F-FDG PET/CT表现提高了预后价值,可能为临床管理提供无创指导。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Anatomical and molecular staging strategies are needed for the personalized treatment of localized pancreatic ductal adenocarcinoma (PDAC). This study evaluated the performance of [68 Ga]Ga-FAPI-04 and [18F]F-FDG PET/CT on the disease staging and prognostic value of patients with localized PDAC on contrast-enhanced (CE)-CT images. METHODS: Patients with suspected localized PDAC on CE-CT were recruited for static [68 Ga]Ga-FAPI-04 and 18[F]F-FDG and PET/CT, and select patients underwent simultaneous 60-min dynamic 68 Ga-FAPI-04 PET/CT. The diagnostic and staging performances of the static PET/CT results were evaluated by delineating regions of interest in the primary tumor, whole pancreas, and distal pancreas in both types of scans and then evaluating correlations between the PET/CT findings and clinicopathological characteristics. Furthermore, Kaplan-Meier and hazard ratio (log-rank) methods were used to evaluate the prognostic value of the combined dynamic [68 Ga]Ga-FAPI-04 and static [18F]F-FDG PET/CT method. RESULTS: We included 49 patients with histologically confirmed PDAC adenocarcinomas; 32 underwent 60-min dynamic [68 Ga]Ga-FAPI-04 PET/CT imaging simultaneously. The static [68 Ga]Ga-FAPI-04 method had significantly higher accuracy and uptake values than the static [18F]F-FDG method for primary PDAC lesions, metastatic lymph nodes, and distal metastases. Furthermore, 18.4% and 10.2% of the patients' stages changed after using the [68 Ga]Ga-FAPI-04 and [18F]F-FDG PET/CT methodologies, respectively, compared to the CE-CT-designated stage. The Ki values obtained from dynamic [68 Ga]Ga-FAPI-04 PET/CT did not differ between PDAC and distal obstructive pancreatitis lesions. Pathologically enlarged tumor size, poor differentiation, and perineural invasion were associated with increased [68 Ga]Ga-FAPI-04 uptake but not with [18F]F-FDG uptake. The preoperative prognostic performance of [68 Ga]Ga-FAPI-04 was better than that of [18F]F-FDG. Interestingly, combined [68 Ga]Ga-FAPI-04 and [18F]F-FDG uptake results in the whole pancreas could further stratify patients based on their postoperative prognosis. CONCLUSION: 6[68 Ga]Ga-FAPI-04 PET/CT was more sensitive and accurate than [18F]F-FDG PET/CT for tumor, node, and metastasis staging of PDAC identified on CE-CT. Additionally, [68 Ga]Ga-FAPI-04 uptake was significantly associated with pathologically aggressive tumor features. Combined [68 Ga]Ga-FAPI-04 and [18F]F-FDG PET/CT findings improved the prognostic value, potentially providing a non-invasive guide for clinical management. Finally, increased fibroblast activity in PDAC-induced obstructive pancreatitis may be associated with poor patient survival rates.
引用
- Ding J, Qiu J, Hao Z, et al. Comparing the clinical value of baseline [68 Ga]Ga-FAPI-04 PET/CT and [18F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis. Eur J Nucl Med Mol Imaging. 2023. PMID: 37493664. doi:10.1007/s00259-023-06297-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。